Respiratory Care Devices Market Size, Share & Forecast Analysis to 2030

The global respiratory care devices market size was valued at over USD 23 billion in 2025 and projected to grow at a significant CAGR of around 8% during the forecast period from 2026 to 2030. The market is witnessing strong growth due to the increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, along with a rapidly aging global population. Rising demand for home-based respiratory care, supported by advancements in portable and connected respiratory devices, is transforming patient management and improving treatment accessibility. Continuous innovation in ventilators, oxygen therapy systems, nebulizers, and remote monitoring technologies is enhancing clinical outcomes while driving product adoption across hospitals and homecare settings.

Market Snapshot:

Market Insights:

• The therapeutic devices dominate the market, driven by high usage of ventilators, oxygen concentrators, and CPAP/BiPAP systems for managing chronic and acute respiratory conditions.
• The chronic obstructive pulmonary disease (COPD) remains the leading indication, creating sustained demand for long-term respiratory support and monitoring solutions.
• The North America holds the largest market share due to advanced healthcare infrastructure, high disease prevalence, and strong adoption of innovative respiratory technologies.
• The rapid shift toward home healthcare and connected respiratory devices is transforming patient care and accelerating the adoption of portable, digital respiratory solutions.

Key Factors Driving the Respiratory Care Devices Market Growth

The rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections is a major factor driving the growth of the respiratory care devices market. Increasing exposure to air pollution, tobacco smoke, occupational hazards, and an aging global population has significantly increased the demand for respiratory support devices, including ventilators, oxygen concentrators, nebulizers, and CPAP systems. Additionally, the growing preference for home healthcare and the adoption of portable, connected respiratory devices are improving patient convenience while reducing hospital admissions.

Technological advancements, including AI-enabled ventilators, smart inhalers, remote patient monitoring, and portable oxygen therapy systems, are further accelerating market expansion by enabling personalized and continuous respiratory care. Government initiatives to strengthen respiratory healthcare infrastructure and rising investments in critical care are also supporting market growth. According to the World Health Organization (WHO) and the European Respiratory Society, chronic respiratory diseases affect approximately 81.7 million people in the WHO European Region alone, with COPD cases projected to increase globally by 23% between 2020 and 2050, underscoring the growing need for advanced respiratory care solutions.

Key Growth Drivers:

• Rising prevalence of COPD, asthma, sleep apnea, and other respiratory diseases is increasing demand for respiratory care devices.
• Growing adoption of home healthcare and portable respiratory devices is driving market expansion.
• Advancements in AI-enabled respiratory technologies and increasing healthcare investments are accelerating product adoption.

Respiratory Care Devices Market Restraining Factors

The high cost of advanced respiratory care devices, including ventilators, oxygen concentrators, and non-invasive ventilation systems, remains a key challenge for market growth. The significant upfront investment, ongoing maintenance expenses, and costs associated with consumables and accessories can limit adoption, particularly among small healthcare facilities and patients in low- and middle-income countries. In addition, inadequate reimbursement policies in certain regions further restrict access to advanced respiratory care solutions.

Another major restraint is the shortage of skilled healthcare professionals trained to operate and maintain sophisticated respiratory equipment, especially in developing economies. Regulatory compliance requirements, lengthy product approval processes, and frequent product recalls can delay the commercialization of new devices and increase operational costs for manufacturers. Moreover, limited healthcare infrastructure and uneven access to respiratory care services in rural and underserved areas continue to hinder broader market penetration.

Future Opportunities Reshaping the Respiratory Care Devices Market’s Evolution

The increasing shift toward home healthcare is creating significant opportunities for the respiratory care devices market. Growing demand for portable oxygen concentrators, CPAP/BiPAP devices, smart inhalers, and remote patient monitoring solutions is encouraging manufacturers to develop compact, connected, and user-friendly devices that improve treatment adherence while reducing hospital visits. The integration of digital health technologies and telemedicine is further expanding access to respiratory care, particularly for patients with chronic respiratory conditions.

Emerging markets are also offering substantial growth potential due to rising healthcare investments, improving healthcare infrastructure, and increasing awareness of respiratory disease management. In addition, continuous product innovation is opening new revenue opportunities for manufacturers. For instance, in June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator, expanding its home oxygen therapy portfolio with a compact, durable solution designed for long-term care patients, reflecting the growing industry focus on accessible and home-based respiratory care.

Key Growth Opportunities:

• Rising demand for home healthcare is increasing the adoption of portable and connected respiratory care devices.
• Expanding healthcare infrastructure and growing healthcare spending in emerging economies are creating new market opportunities.
• Continuous innovation in smart inhalers, AI-enabled respiratory devices, and remote patient monitoring solutions is driving future growth.

Industry Trends Shaping the Global Respiratory Care Devices Market

The global respiratory care devices market is witnessing a strong shift toward connected and home-based care, with manufacturers integrating artificial intelligence (AI), Internet of Medical Things (IoMT), and remote patient monitoring capabilities into respiratory devices. Smart inhalers, portable oxygen concentrators, wearable respiratory monitors, and cloud-connected ventilators are gaining popularity as healthcare providers increasingly focus on personalized treatment, early intervention, and reduced hospital readmissions. The growing adoption of telehealth is also accelerating demand for digitally enabled respiratory care solutions.

Another key trend is the development of compact, patient-friendly devices designed to improve mobility, comfort, and long-term disease management. Manufacturers are investing in innovative airway clearance systems, wearable monitoring technologies, and advanced nebulizers to enhance patient outcomes and expand home-based care. For example, in July 2025, Synchrony Medical received U.S. FDA 510(k) clearance for its LibAirty™ Airway Clearance System, an app-guided, home-use device developed to improve airway clearance for patients with chronic lung diseases, highlighting the industry’s focus on innovative and accessible respiratory care technologies.

Market Segments Insights:

By Product Type: The Therapeutics Devices Sub-category Holds the Largest Revenue Share of Global Respiratory Care Devices Market

The global respiratory care devices market is bifurcated into product type, indication, end-user, distribution channel, and geography. On the basis of product type, the therapeutic devices dominated the global market due to their essential role in the treatment and long-term management of respiratory conditions such as COPD, asthma, sleep apnea, and acute respiratory failure. Products including ventilators, oxygen concentrators, nebulizers, CPAP/BiPAP devices, and inhalers are widely adopted across hospitals, intensive care units, emergency departments, and home healthcare settings. The increasing prevalence of chronic respiratory diseases, rising geriatric population, and growing demand for home-based respiratory therapy continue to strengthen the segment’s leading market position.

The segment is also benefiting from rapid technological advancements, including AI-powered ventilation systems, connected CPAP devices, and portable oxygen therapy solutions that enhance patient comfort and treatment adherence. For instance, in April 2025, Resmed announced the nationwide U.S. availability of its FDA-cleared NightOwl™ home sleep apnea test, designed to simplify the diagnosis of obstructive sleep apnea and improve access to CPAP therapy, reflecting the continued innovation driving demand for therapeutic respiratory care solutions.

By Indication: The COPD Segment Dominated the Global Respiratory Care Devices Market

On the basis of indication, the global respiratory care devices market is further segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious respiratory diseases, and others. The chronic obstructive pulmonary disease (COPD) dominates the market due to its high global prevalence and the lifelong need for respiratory support, monitoring, and disease management. COPD patients frequently require oxygen concentrators, ventilators, nebulizers, CPAP/BiPAP systems, and pulmonary monitoring devices to manage symptoms, prevent exacerbations, and improve quality of life. Rising exposure to smoking, air pollution, occupational hazards, and population aging continues to drive demand for respiratory care devices in this segment.

The segment also benefits from continuous advancements in respiratory therapies, portable oxygen delivery systems, and remote patient monitoring technologies that support long-term disease management. According to the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report, COPD remains one of the leading causes of death worldwide, and the updated guidelines introduce new recommendations to improve diagnosis and optimize long-term pharmacological management, highlighting the growing clinical focus on COPD care and the sustained demand for advanced respiratory care devices.

The respiratory care devices market research report presents the analysis of each segment from 2020 to 2030 considering 2025 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2026 to 2030.

Global Respiratory Care Devices Market Segmentation:

By Type:

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Application:

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Sleep Apnea
• Infectious Respiratory Diseases
• Others

By End-User:

• Hospitals
• Ambulatory Care Centers
• Home Care

By Distribution Channel:

• Direct Sales
• Retail Pharmacies
• Online Sales
• Medical Device Distributors

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: The North America Leading the Global Respiratory Care Devices Market

Geographically, the North America dominates the respiratory care devices market due to its advanced healthcare infrastructure, high prevalence of chronic respiratory diseases, favorable reimbursement policies, and rapid adoption of innovative respiratory technologies. The region has a well-established network of hospitals, specialty clinics, and home healthcare providers, driving strong demand for ventilators, oxygen concentrators, CPAP/BiPAP devices, nebulizers, and respiratory monitoring systems. Moreover, the presence of leading medical device manufacturers and continuous investments in respiratory care innovation further strengthen the region’s market leadership.

The region’s dominance is also supported by the substantial burden of respiratory diseases in the United States, which continues to fuel demand for diagnosis, treatment, and long-term disease management. According to the U.S. Centers for Disease Control and Prevention (CDC), 3.8% of U.S. adults aged 18 years and older were diagnosed with chronic obstructive pulmonary disease (COPD) in 2023, with prevalence increasing to 10.5% among adults aged 75 years and older, highlighting the sustained need for advanced respiratory care devices across the country.

Competitive Analysis:

The respiratory care devices market is highly competitive, with leading companies focusing on product innovation, strategic collaborations, mergers and acquisitions, and global expansion to strengthen their market positions. Koninklijke Philips N.V., ResMed Inc., Medtronic plc, Fisher & Paykel Healthcare Corporation Limited, and GE HealthCare Technologies Inc. are among the top market players, offering comprehensive portfolios of ventilators, CPAP/BiPAP devices, oxygen therapy systems, respiratory monitoring solutions, and other advanced respiratory care technologies. These companies continue to invest in research and development to introduce connected, portable, and AI-enabled respiratory devices.

Competition is further driven by continuous product launches, regulatory approvals, and the integration of digital health technologies to improve patient outcomes and support home-based respiratory care. Leading manufacturers are expanding their presence in emerging markets through strategic partnerships, localized manufacturing, and strengthened distribution networks. In addition, increasing investments in cloud-connected respiratory monitoring, telehealth-enabled solutions, and wearable respiratory devices are enabling companies to differentiate their offerings and capture a larger share of the rapidly evolving respiratory care devices market.

Key Companies:

• Koninklijke Philips N.V.
• ResMed Inc.
• Medtronic plc
• Fisher & Paykel Healthcare Corporation Limited
• GE HealthCare Technologies Inc.
• Drägerwerk AG & Co. KGaA
• Getinge AB
• Hamilton Medical AG
• Vyaire Medical, Inc.
• ICU Medical, Inc.
• Masimo Corporation
• Air Liquide Healthcare

Global Respiratory Care Devices Market Outlook

• Rising prevalence of chronic respiratory diseases and an aging population will continue to drive long-term demand for respiratory care devices.
• Growing adoption of home healthcare and remote patient monitoring will accelerate the use of portable and connected respiratory solutions.
• Advancements in AI-enabled ventilators, smart inhalers, and digital respiratory monitoring technologies will enhance patient care and expand market opportunities.
• Increasing healthcare investments and expanding access to respiratory care in emerging economies will support sustained global market growth.

Global Respiratory Care Devices Market FAQs: